High-Frequency MRI Monitoring Should Be Performed in Natalizumab-Treated MS Patients With Higher Risk of PML – Commentary

Multiple Sclerosis - United States
doi 10.1177/1352458516685170
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications


Related search